Putnak JR - Search Results

1

Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2b.

Putnak JR, Schlesinger JJ. Putnak JR, et al. J Gen Virol. 1990 Aug;71 ( Pt 8):1697-702. doi: 10.1099/0022-1317-71-8-1697. J Gen Virol. 1990. PMID: 2144016

2

Cell surface expression of yellow fever virus non-structural glycoprotein NS1: consequences of interaction with antibody.

Schlesinger JJ, Brandriss MW, Putnak JR, Walsh EE. Schlesinger JJ, et al. Among authors: putnak jr. J Gen Virol. 1990 Mar;71 ( Pt 3):593-9. doi: 10.1099/0022-1317-71-3-593. J Gen Virol. 1990. PMID: 2138210

3

New approaches to flavivirus vaccine development.

Schlesinger JJ, Putnak JR, Eckels KH. Schlesinger JJ, et al. Among authors: putnak jr. Biotechnology. 1992;20:289-307. doi: 10.1016/b978-0-7506-9265-6.50018-x. Biotechnology. 1992. PMID: 1318137 Review. No abstract available.

4

Functional and antigenic domains of the dengue-2 virus nonstructural glycoprotein NS-1.

Putnak JR, Charles PC, Padmanabhan R, Irie K, Hoke CH, Burke DS. Putnak JR, et al. Virology. 1988 Mar;163(1):93-103. doi: 10.1016/0042-6822(88)90236-x. Virology. 1988. PMID: 2964755

5

Mice immunized with a dengue type 2 virus E and NS1 fusion protein made in Escherichia coli are protected against lethal dengue virus infection.

Srivastava AK, Putnak JR, Warren RL, Hoke CH Jr. Srivastava AK, et al. Among authors: putnak jr. Vaccine. 1995 Sep;13(13):1251-8. doi: 10.1016/0264-410x(94)00059-v. Vaccine. 1995. PMID: 8578812

6

Short report: absence of protective neutralizng antibodies to West Nile virus in subjects following vaccination with Japanese encephalitis or dengue vaccines.

Kanesa-Thasan N, Putnak JR, Mangiafico JA, Saluzzo JE, Ludwig GV. Kanesa-Thasan N, et al. Among authors: putnak jr. Am J Trop Med Hyg. 2002 Feb;66(2):115-6. doi: 10.4269/ajtmh.2002.66.115. Am J Trop Med Hyg. 2002. PMID: 12135278

7

Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination.

Sun W, Nisalak A, Gettayacamin M, Eckels KH, Putnak JR, Vaughn DW, Innis BL, Thomas SJ, Endy TP. Sun W, et al. Among authors: putnak jr. J Infect Dis. 2006 Jun 15;193(12):1658-65. doi: 10.1086/503372. Epub 2006 May 9. J Infect Dis. 2006. PMID: 16703509

8

A purified inactivated Japanese encephalitis virus vaccine made in Vero cells.

Srivastava AK, Putnak JR, Lee SH, Hong SP, Moon SB, Barvir DA, Zhao B, Olson RA, Kim SO, Yoo WD, Towle AC, Vaughn DW, Innis BL, Eckels KH. Srivastava AK, et al. Among authors: putnak jr. Vaccine. 2001 Aug 14;19(31):4557-65. doi: 10.1016/s0264-410x(01)00208-0. Vaccine. 2001. PMID: 11483284

9

Atypical antibody responses in dengue vaccine recipients.

Kanesa-Thasan N, Sun W, Ludwig GV, Rossi C, Putnak JR, Mangiafico JA, Innis BL, Edelman R. Kanesa-Thasan N, et al. Among authors: putnak jr. Am J Trop Med Hyg. 2003 Dec;69(6 Suppl):32-8. doi: 10.4269/ajtmh.2003.69.32. Am J Trop Med Hyg. 2003. PMID: 14740953

10

Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates.

Sun W, Edelman R, Kanesa-Thasan N, Eckels KH, Putnak JR, King AD, Houng HS, Tang D, Scherer JM, Hoke CH Jr, Innis BL. Sun W, et al. Among authors: putnak jr. Am J Trop Med Hyg. 2003 Dec;69(6 Suppl):24-31. doi: 10.4269/ajtmh.2003.69.6_suppl.0690024. Am J Trop Med Hyg. 2003. PMID: 14740952 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

34 results

Search Page